Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by blackjack0on Feb 20, 2020 11:06am

156 Views

Post# 30712877

RE:News Release. 10 Patients Treated!

So much for the usual negative ninnies suggestions that the Canadian side is slowed down. The increase in treatments to date is exactly what I was told about a week ago by investor relations. I was told Canada is not the USA and the study is full steam ahead in Canada. She was truthful in what she told me. Just a matter of time people

Bullboard Posts

A Look into the Future of Chronic Pain Management